Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

<p>Abstract</p> <p>Background</p> <p>The prognosis of pT1a-pT1b breast cancer (BC) used to be considered very good, with a 10-y RFS of 90%. However, some retrospective studies reported a 10-y RFS of 81%–86% and suggested benefit from adjuvant systemic therapy.</p> <p>Methods</p> <p>To evaluate the v...

全面介紹

書目詳細資料

Principais autores:	Gori Stefania, Clavarezza Matteo, Siena Salvatore, Foglietta Jennifer, Tarenzi Emiliana, Giordano Monica, Molino Annamaria, Graiff Claudio, Fusco Vittorio, Alabiso Oscar, Baldini Editta, Gamucci Teresa, Altavilla Giuseppe, Dondi Davide, Venturini Marco
格式:	Artigo
語言:	Inglês
出版:	BMC 2012-04-01
叢編:	BMC Cancer
主題:	pT1a and pT1b breast cancer Adjuvant chemotherapy Adjuvant hormonal therapy
在線閱讀:	http://www.biomedcentral.com/1471-2407/12/158
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!